Santen Pharmaceutical Completes Share Buyback Totaling 31.90 Billion Yen

Reuters
2025.11.06 06:35
portai
I'm PortAI, I can summarize articles.

Santen Pharmaceutical Co., Ltd. has completed its share buyback program, repurchasing 19,800,000 common shares for approximately 31.90 billion yen. The buyback was executed through open-market repurchases as per a Board of Directors resolution.

Santen Pharmaceutical Co., Ltd. announced the completion of its share buyback program, repurchasing a total of 19,800,000 common shares for approximately 31,896,010,850 yen. The buyback was conducted via open-market repurchases by the discretionary trading method, in accordance with a Board of Directors resolution. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Santen Pharmaceutical Co. Ltd. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.